GE scientists learning to make vaccines on demand
FacebookTwitterEmail
3of3
NISKAYUNA Scientists at General Electric Co s research lab here are learning how to make vaccines on demand as part of a project that could one day help the military craft thousands of doses in hard-to-reach places in just a matter of days.
GE Research is part of a larger team of scientists from the Broad Institute in Cambridge, Mass., the University of Washington and elsewhere that were recently awarded $41 million to help create components of a mobile vaccine manufacturing system for the Defense Department that would build upon the ribonucleic acid, or RNA, technology used in Pfizer and Moderna s COVID-19 vaccines.
Share this article
SAN DIEGO, March 2, 2021 /PRNewswire/
Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, today announced the company s participation in a new project with a multidisciplinary team, led by GE Research, to enable the production of DNA- and/or RNA-based vaccines and therapeutics, anywhere in the world in just days. The project is part of a new program from the
Defense Advanced Research Projects Agency (DARPA) called
NOW (Nucleic Acids On-Demand Worldwide). As part of the project, Molecular Assemblies will receive up to $6.5 million and contribute the company s proprietary enzymatic DNA synthesis technology, which uses aqueous, non-toxic reagents and is designed to deliver on-demand highly-pure, sequence-specific DNA.
Molecular Assemblies to Provide Enzymatic Synthesis Technology to DARPA NOW Project for On-Demand DNA/RNA Vaccine Manufacturing prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.